Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4817159 | 6040618 | I | 4817159-4 | 20050620 | 20051018 | PER | PHEH2005US05891 | NOVARTIS PHARMACEUTICALS CORP. | 62 | YR | F | N | 20050829 | MD | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4817159 | 1006582292 | PS | ZOMETA | 1 | INTRAVENOUS | 4 MG IN JAN, FEB AND MAR 2005, INTRAVENOUS | N | D | 21223 | ||
| 4817159 | 1006612783 | C | MEGASTROL (MEGESTROL) | 2 | |||||||
| 4817159 | 1006612784 | C | LIPITOR | 1 | |||||||
| 4817159 | 1006612785 | C | TAXOL | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4817159 | 1006582292 | OSTEOPOROSIS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4817159 | DS |
Reactions reported
| Event ID | PT |
|---|---|
| 4817159 | ARTHRALGIA |
| 4817159 | BONE PAIN |
| 4817159 | MYALGIA |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4817159 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4817159 | 1006582292 | 20050125 | 20050301 |